Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry. Academic Article uri icon

Overview

abstract

  • Not available.

authors

publication date

  • April 4, 2024

Identity

Digital Object Identifier (DOI)

  • 10.3324/haematol.2023.284678

PubMed ID

  • 38572549